Evidence map›Paper›PMID 38271464›Full record

ArticlePLoS pathogens2024

Type 3 secretion system induced leukotriene B4 synthesis by leukocytes is actively inhibited by Yersinia pestis to evade early immune recognition.

Amanda Brady, Katelyn R Sheneman, Amanda R Pulsifer, Sarah L Price, Taylor M Garrison, Krishna Rao Maddipati, Sobha R Bodduluri, Jianmin Pan, Nolan L Boyd, Jing-Juan Zheng and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Approaches for the Inactivation ofApplied biosafety : journal of the American Biological Safety Association · 2024
    Article
  5. Article
  6. Distinct Mechanisms of Type 3 Secretion System Recognition Control LTBbioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Amanda BradyDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Katelyn R ShenemanDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Amanda R PulsiferDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Sarah L PriceDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Taylor M GarrisonDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Krishna Rao MaddipatiDepartment of Pathology, Lipidomics Core Facility, Wayne State University, Detroit, Michigan, United States of America.
Sobha R BodduluriDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Jianmin PanBiostatistics and Bioinformatics Facility, Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States of America.
Nolan L BoydCenter for Cardiometabolic Science, Christina Lee Brown Environment Institute, Division of Environmental Medicine, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Jing-Juan ZhengCenter for Cardiometabolic Science, Christina Lee Brown Environment Institute, Division of Environmental Medicine, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Shesh N RaiDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Jason HellmannCenter for Cardiometabolic Science, Christina Lee Brown Environment Institute, Division of Environmental Medicine, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Bodduluri HaribabuDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Silvia M UriarteDeptartment of Oral Immunology & Infectious Diseases, University of Louisville, Louisville, Kentucky, United States of America.
Matthew B LawrenzDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.ORCID 0000-0003-1505-5429
University of Louisville · USWayne State University · US

Funding

Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative IntravaginalP20GM125504 · NIGMS · UNIVERSITY OF LOUISVILLE · PI HARIBABU BODDULURI · 2018 to 2026
$24.4M
TBDP30GM127607 · NIGMS · UNIVERSITY OF LOUISVILLE · PI JONES, STEVEN P · 2018 to 2022
$6.3M
Iron independent role for yersiniabactin in Yersinia pestisR01AI148241 · NIAID · UNIVERSITY OF LOUISVILLE · PI LAWRENZ, MATTHEW B · 2021 to 2025
$3.1M
Impact of inflammatory lipids on Yersinia pestis infectionR01AI178106 · NIAID · UNIVERSITY OF LOUISVILLE · PI Matthew B Lawrenz · 2023 to 2026
$2.9M
Exercise-enhanced resolution of inflammationR01GM127495 · NIGMS · UNIVERSITY OF LOUISVILLE · PI HELLMANN, JASON L · 2018 to 2022
$2.5M
Inflammation and Pathogenesis Training ProgramT32AI132146 · NIAID · UNIVERSITY OF LOUISVILLE · PI LAMONT, RICHARD J, MITCHELL, THOMAS C. · 2018 to 2022
$640k
Triple Quadrupole - Ion Trap Hybrid LC/MS/MS SystemS10RR027926 · NCRR · WAYNE STATE UNIVERSITY · PI MADDIPATI, KRISHNARAO · 2010 to 2010
$425k
Defining the impact of Extracellular Vesicles on inflammation during pneumonic plagueF31AI178999 · NIAID · UNIVERSITY OF LOUISVILLE · PI SHENEMAN, KATELYN RENEE · 2023 to 2025
$107k
Identification of a novel zinc acquisition system in Yersinia pestisF31AI147404 · NIAID · UNIVERSITY OF LOUISVILLE · PI PRICE, SARAH LEANN · 2019 to 2022
$97k
NCRR NIH HHS S10 RR027926NIAID NIH HHS F31 AI147404NIAID NIH HHS F31 AI178999NIAID NIH HHS R01 AI148241NIAID NIH HHS R01 AI178106NIAID NIH HHS T32 AI132146NIGMS NIH HHS P20 GM125504NIGMS NIH HHS P30 GM127607NIGMS NIH HHS R01 GM127495
6 · The paper itself

Abstract

Subverting the host immune response to inhibit inflammation is a key virulence strategy of Yersinia pestis. The inflammatory cascade is tightly controlled via the sequential action of lipid and protein mediators of inflammation. Because delayed inflammation is essential for Y. pestis to cause lethal infection, defining the Y. pestis mechanisms to manipulate the inflammatory cascade is necessary to understand this pathogen's virulence. While previous studies have established that Y. pestis actively inhibits the expression of host proteins that mediate inflammation, there is currently a gap in our understanding of the inflammatory lipid mediator response during plague. Here we used the murine model to define the kinetics of the synthesis of leukotriene B4 (LTB4), a pro-inflammatory lipid chemoattractant and immune cell activator, within the lungs during pneumonic plague. Furthermore, we demonstrated that exogenous administration of LTB4 prior to infection limited bacterial proliferation, suggesting that the absence of LTB4 synthesis during plague contributes to Y. pestis immune evasion. Using primary leukocytes from mice and humans further revealed that Y. pestis actively inhibits the synthesis of LTB4. Finally, using Y. pestis mutants in the Ysc type 3 secretion system (T3SS) and Yersinia outer protein (Yop) effectors, we demonstrate that leukocytes recognize the T3SS to initiate the rapid synthesis of LTB4. However, several Yop effectors secreted through the T3SS effectively inhibit this host response. Together, these data demonstrate that Y. pestis actively inhibits the synthesis of the inflammatory lipid LTB4 contributing to the delay in the inflammatory cascade required for rapid recruitment of leukocytes to sites of infection.

Indexed as

PlagueYersinia pestisAnimalsBacterial ProteinsHumansInflammationLeukocytesLeukotriene B4MiceType III Secretion SystemsBacterial ProteinsLeukotriene B4Type III Secretion Systems

Identifiers

PMID38271464
PMCPMC10846697
OpenAlexW4391215498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.